{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/06/15/3311657/0/en/Elicio-Therapeutics-Reports-Results-from-Phase-2-AMPLIFY-7P-Study-and-Outlines-Refined-Phase-3-Development-Strategy-for-ELI-002-7P-in-Adjuvant-Pancreatic-Cancer.html", "message": "News view counter 798711 successfully enlarged"}